Does PEMBROLIZUMAB Cause Decreased appetite? 2,486 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,486 reports of Decreased appetite have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 3.0% of all adverse event reports for PEMBROLIZUMAB.
2,486
Reports of Decreased appetite with PEMBROLIZUMAB
3.0%
of all PEMBROLIZUMAB reports
371
Deaths
1,235
Hospitalizations
How Dangerous Is Decreased appetite From PEMBROLIZUMAB?
Of the 2,486 reports, 371 (14.9%) resulted in death, 1,235 (49.7%) required hospitalization, and 126 (5.1%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Hypothyroidism (2,326)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which PEMBROLIZUMAB Alternatives Have Lower Decreased appetite Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G